GLOW
70 mg
€ 100,00
totalComing soonGLOW — 70 mg per research vial: GHK-Cu 50 mg, TB-500 10 mg and BPC-157 10 mg. For research purposes only. Not for human consumption or therapeutic use.
- Reference
- MVP / 007
- Strength
- 70 mg
- Availability
- Coming soon
- Handling
- Store cool and dry, away from light. Laboratory handling only.
- Shipping
- PostNL within the Netherlands: € 4,99 per order; free over € 120,00
Specification
For research only. Not for human use.
Key research areas
- Tri-peptide blend interactions (GHK-Cu, TB-500, BPC-157)
- Fibroblast and collagen-process biology
- Cell migration in connective-tissue models
- Cytoskeletal and actin-related mechanisms
- Skin- and tissue-research frameworks
Potential benefits observed in research
- GHK-Cu component is linked in research to collagen synthesis and skin-quality markers.
- BPC-157 and TB-500 components are studied for cell-migration and tissue-response effects.
- Provides a combined subject for exploring recovery-pathway interactions.
- Component findings include antioxidant and matrix-support observations.
Reported observations from published studies under controlled conditions. They do not establish the safety, quality or performance of this research material.
Research documentation
GLOW — 70 mg
GLOW combines GHK-Cu 50 mg, TB-500 10 mg and BPC-157 10 mg, providing a stated total of 70 mg per vial. Its components connect several areas of connective-tissue and cellular research. GHK-Cu, a copper-binding tripeptide, has been investigated in fibroblast and collagen studies. BPC-157 has been examined in laboratory and animal models involving tendon-cell migration and survival. TB-500 is associated with thymosin beta-4 fragment research, where exact molecular identity determines which findings are relevant. The combination creates a subject for investigating interactions between these research pathways.
However, evidence on separate components does not establish synergy, improved recovery or clinical benefit for this blend. No human therapeutic effect is established for the MVP formulation. GHK-Cu research; BPC-157 research; TB-500 identity review.
For research purposes only. Not for human consumption or therapeutic use.
